275 related articles for article (PubMed ID: 14979429)
1. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.
Paradis MA; Vessie GH; Merrill JK; Dick CP; Moore C; Charbonneau G; Gottschalk M; MacInnes JI; Higgins R; Mittal KR; Girard C; Aramini JJ; Wilson JB
Can J Vet Res; 2004 Jan; 68(1):7-11. PubMed ID: 14979429
[TBL] [Abstract][Full Text] [Related]
2. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
Moore GM; Basson RP; Tonkinson LV
Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
[TBL] [Abstract][Full Text] [Related]
3. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine.
Moore GM; Mowrey DH; Tonkinson LV; Lechtenberg KF; Schneider JH
Am J Vet Res; 1996 Feb; 57(2):220-3. PubMed ID: 8633812
[TBL] [Abstract][Full Text] [Related]
4. Experimental infections with Actinobacillus pleuropneumoniae in pigs--II. Comparison of antibiotics for oral strategic treatment.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):261-9. PubMed ID: 10379236
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.
Fittipaldi N; Klopfenstein C; Gottschalk M; Broes A; Paradis MA; Dick CP
Can J Vet Res; 2005 Apr; 69(2):146-50. PubMed ID: 15971680
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs.
Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A
J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
9. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
[TBL] [Abstract][Full Text] [Related]
10. Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):249-60. PubMed ID: 10379235
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.
Dong Z; Zhou XZ; Sun JC; Meng XB; Li HS; Cheng FS; Wei XJ; Li B; Wang WW; Zhang JY
Vet Med Sci; 2020 Feb; 6(1):105-113. PubMed ID: 31589010
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
Stipkovits L; Miller D; Glavits R; Fodor L; Burch D
Can J Vet Res; 2001 Oct; 65(4):213-22. PubMed ID: 11768127
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an Actinobacillus pleuropneumoniae seeder pig challenge-exposure model.
Lechtenberg KF; Shryock TR; Moore G
Am J Vet Res; 1994 Dec; 55(12):1703-9. PubMed ID: 7887514
[TBL] [Abstract][Full Text] [Related]
14. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae.
Marois C; Gottschalk M; Morvan H; Fablet C; Madec F; Kobisch M
Vet Microbiol; 2009 Mar; 135(3-4):283-91. PubMed ID: 18977616
[TBL] [Abstract][Full Text] [Related]
15. Experimental model of swine pneumonic pasteurellosis using crude Actinobacillus pleuropneumoniae cytotoxin and Pasteurella multocida given endobronchially.
Chung WB; Bäckström LR; Collins MT
Can J Vet Res; 1994 Jan; 58(1):25-30. PubMed ID: 8143249
[TBL] [Abstract][Full Text] [Related]
16. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Shryock TR; Staples JM; DeRosa DC
J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral enrofloxacin and florfenicol on pigs experimentally infected with Actinobacillus pleuropneumoniae serotype 1.
Herradora LM; Martínez-Gamba R
J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):259-63. PubMed ID: 14567514
[TBL] [Abstract][Full Text] [Related]
18. Effect of giving enrofloxacin in the diet to pigs experimentally infected with Actinobacillus pleuropneumoniae.
Smith IM; Mackie A; Lida J
Vet Rec; 1991 Jul; 129(2):25-9. PubMed ID: 1926685
[TBL] [Abstract][Full Text] [Related]
19. Blood gas stability and hematological changes in experimentally-induced acute porcine pleuropneumonia.
Kiorpes AL; Mirsky ML; MacWilliams PS; Bäckström LR; Collins MT
Can J Vet Res; 1989 Jan; 53(1):95-9. PubMed ID: 2914231
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
